Background
Methods
Eligibility criteria
Data sources and search strategy
Literature selection and data extraction
Quality assessment
Statistical analysis
Results
Literature search and characteristics of the included studies
Characteristics of the included studies
Full name | Abbreviations |
---|---|
Aspirin + Anticoagulants + Dehydrant + Neuroprotectant | AADN |
Ligustrazine injection | LI |
Xueshuantong injection | XST1 |
Xuesaitong injection | XST2 |
Shuxuening injection | SXN |
Dengzhanxixin injection | DZXX |
Dengzhanhuasu injection | DZHS |
Shuxuetong injection | SXT |
Danhong injection | DH |
Fufangdanshen injection | FFDS |
Yinxingdamo injection | YXDM |
Mailuoning injection | MLN |
Honghuahuangsesu injection | HHHSS |
Shenxiong glucose injection | SX |
Danshen Chuanxiongqin injection | DSCXQ |
Danshen injection | DS |
Study | Acute phase | Sex (M/F) | Age | Experimental group | Control group | Course | Outcomes | ADRs/ADEs | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | T1 | Dosage | N | T2 | Dosage | |||||||
Yu YC 2014 | 72 h | 38/30 | 62.5 (44–76) | 34 | XST1 | 500 mg | 34 | AADN | – | 14d | (1) | None |
Yu YM 2009 | 72 h | 71/45 | 62.5 (40–72) | 58 | DH | 20 ml | 58 | FFDS | 20 ml | 15d | (1)(2) | Unclear |
Yu Y 2015 | 72 h | 35/21 | 54.3 (38–71) | 28 | XST1 | 500 mg | 28 | FFDS | 20 ml | 14d | (1)(2) | 6 |
Zhang ZJ 2008 | 74 h | 41/30 | 64.3 | 35 | SX | 100 ml | 36 | FFDS | 20 ml | 14d | (1) | None |
Zheng XD 2007 | 72 h | 39/21 | 66.4 | 30 | YXDM | 20 mL | 30 | FFDS | 30 ml | 14d | (1) | None |
Zhou SJ 2011 | 1 M | 46/34 | 62 (42–75) | 40 | SX | 100 ml | 40 | AADN | – | 14d | (1)(2) | None |
Zhou SF 2009 | 48 h | 52/42 | 65.6 (62–86) | 48 | SX | 200 ml | 46 | FFDS | 20 mL | 21d | (1)(2) | 10 |
Zhou SH 2013 | 72 h | 50/40 | 62 | 45 | SXN | 20 ml | 45 | AADN | – | 14d | (1)(4) | None |
Xu XY 2011 | 12 h | 40/20 | 55.9 (45–73) | 30 | YXDM | 20 ml | 30 | DS | 20 ml | 21d | (1)(2)(3) | Unclear |
Xie S 2011 | 24 h | 42/30 | 61.4 (53–78) | 36 | SXT | 6 ml | 36 | FFDS | 20 ml | 14d | (1) | None |
Xie YG 2010 | 48 h | 39/31 | 61.6 (50–76) | 35 | SXT | 6 ml | 35 | DZHS | 50 mg | 14d | (1)(2) | None |
Xu LL 2011 | 72 h | 48/34 | 63.0 (55–81) | 42 | LI | 120 mg | 42 | AADN | – | 14d | (1)(2) | Unclear |
Xu XQ 2012 | 72 h | 64/44 | 57.9 | 54 | YXDM | 20 ml | 54 | FFDS | 20 ml | 14d | (1)(2) | 1 |
Yang HJ 2007 | 24 h | 50/34 | 53.6 (39–75) | 48 | DSCXQ | 10 ml | 36 | FFDS | 10 ml | 30d | (1)(2) | 1 |
Yang YF 2012 | 48 h | – | 68 | 112 | DH | 30 ml | 101 | AADN | – | 21d | (1)(2) | Unclear |
Yao QY 2010 | 72 h | 64/40 | 70.8 (54–82) | 56 | SXT | 6 ml | 48 | LI | 12 ml | 14d | (1)(2) | 2 |
Yao J 2010 | 72 h | 37/27 | 60.5 (49–76) | 32 | YXDM | 20 ml | 32 | DZHS | 50 mg | 14d | (1)(2) | None |
Xie RP 2010 | 72 h | 52/28 | 42–80 | 40 | SXN | 20 ml | 40 | FFDS | 20 mL | 15d | (1) | None |
Tan SY 2016 | 72 h | 49/37 | 39–82 | 43 | DH | 30 ml | 43 | AADN | – | 14d | (1)(2) | None |
Wang WP 2015 | 72 h | 49/41 | 68.2 (60–78) | 45 | SXN | 20 mL | 45 | FFDS | 20 mL | 14d | (1)(2) | Unclear |
Ren HM 2009 | 72 h | 38/26 | 40–78 | 32 | SX | 100 ml | 32 | AADN | – | 14d | (1)(2) | None |
Sun HJ 2013 | 72 h | 42/36 | 60.9 (40–70) | 39 | LI | 120 mg | 39 | AADN | – | 14d | (1)(2) | Unclear |
Tang JP 2013 | 72 h | 47/45 | 51.8 (43–73) | 46 | HHHSS | 100 mg | 46 | AADN | – | 14d | (1)(2) | None |
Tang FY 2009 | 72 h | 39/33 | 64.0 (50–78) | 36 | DZHS | 50 mg | 36 | AADN | – | 14d | (1)(2) | None |
Tang XJ 2013 | 72 h | 45/33 | 58 | 39 | YXDM | 20 mg | 39 | AADN | – | 14d | (1)(2) | None |
Wang L 2010 | 48 h | 26/22 | 65.6 (62–86) | 40 | SX | 200 mL | 40 | FFDS | 20 mL | 21d | (1)(2) | Unclear |
Wang YL 2013 | 168 h | 33/23 | 32–88 | 28 | SXT | 6 ml | 28 | DZHS | 40 ml | 14d | (2) | Unclear |
Lan Y 2015 | 72 h | 41/39 | 54–72 | 40 | DSCXQ | 10 ml | 40 | AADN | – | 14d | (1)(2) | 3 |
Li M 2014 | 24 h | 63/17 | 48–76 | 40 | DH | 30 ml | 40 | AADN | – | 14d | (2) | Unclear |
Liu YP 2010 | 72 h | 45/35 | 51–71 | 40 | DH | 40 ml | 40 | AADN | – | 15d | (1) | 1 |
Ma J 2010 | 24 h | 29/31 | 59.1 (50–68) | 30 | DZHS | 20 mg | 30 | AADN | – | 14d | (1)(2) | Unclear |
Ma J 2015 | 72 h | 49/41 | 65.5 (45–79) | 45 | DH | 20 ml | 45 | AADN | – | 28d | (1)(4) | Unclear |
Chen H 2015 | 24 h | 74/60 | 59.4 (46–87) | 67 | SXT | 6 ml | 67 | AADN | – | 14d | (1)(2) | 5 |
Luan T 2014 | 48 h | 52/43 | 57.5 | 50 | XST2 | 0.4 g | 45 | DS | 20 ml | 15d | (1)(4) | 7 |
Huang ML 2012 | 72 h | 158/142 | 62.6 (42–71) | 150 | XST1 | 500 mg | 150 | DS | 25 ml | 14d | (1) | 1 |
Li X 2015 | 72 h | 129/71 | 62.9 | 100 | HHHSS | 0.1 g | 100 | AADN | – | 14d | (1)(2) | Unclear |
Ma ZL 2011 | 72 h | 74/46 | 62.8 (45–84) | 60 | HHHSS | 0.1 g | 60 | AADN | – | 14d | (1)(2) | None |
Zhang Y 2012 | 48 h | 52/28 | 57.5 (35–80) | 40 | DSCXQ | 100 mg | 40 | AADN | – | 14d | (1)(2) | 1 |
Liu M 2014 | 48 h | 79/57 | 60.2 (40–76) | 68 | DSCXQ | 10 mL | 68 | AADN | – | 14d | (1)(2) | 2 |
Chen YC 2011 | 72 h | 44/24 | 57.9 | 34 | YXDM | 20 ml | 34 | FFDS | 20 ml | 14d | (1)(2) | 1 |
Yang RF 2013 | 48 h | 52/48 | 60.8 (30–83) | 50 | SXT | 6 g | 50 | AADN | – | 14d | (1) | Unclear |
Lin YF 2008 | 72 h | 39/21 | 66.5 | 30 | YXDM | 20 ml | 30 | FFDS | 20 ml | 14d | (1)(3) | None |
Peng T 2006 | 48 h | 51/48 | 68 | 49 | SXT | 7 ml | 50 | FFDS | 20 ml | 14d | (1)(3) | 1 |
Li XH 2011 | 168 h | – | 63.5(40–78) | 120 | SXN | 20 ml | 120 | AADN | – | 14d | (1)(2) | Unclear |
Liu L 2015 | 6-72 h | 74/46 | 61.4 (39–76) | 60 | DH | 20 ml | 60 | SXN | 20 ml | 14d | (1) | None |
Zhang YH 2010 | 6-72 h | 62/34 | 58.9 (39–81) | 48 | DH | 30 ml | 48 | XST2 | 400 mg | 14d | (1)(2) | 5 |
Fan J 2006 | 72 h | 56/32 | 64 (41–82) | 44 | YXDM | 20 ml | 44 | FFDS | 20 ml | 14d | (2) | Unclear |
Liu HY 2014 | 96 h | 67/57 | 61.9 (38–83) | 64 | XST2 | 0.4 g | 60 | FFDS | 30 ml | 15d | (1) | None |
Li FQ 2010 | 72 h | 74/46 | 64 | 60 | YXDM | 30 ml | 60 | FFDS | 40 ml | 15d | (1) | Unclear |
Lian CL 2013 | 360 h | 49/43 | 62 (43–77) | 46 | LI | 120 mg | 46 | AADN | – | 30d | (1) | None |
Chen S 2006 | 72 h | 81/53 | 67.9 | 70 | XST2 | 800 mg | 64 | XST1 | 10 ml | 14d | (1)(2) | None |
Cao LZ 2012 | 72 h | 71/9 | 59.3 | 40 | XST2 | 500 mg | 40 | FFDS | 1.0 g | 14d | (1)(2) | Unclear |
Liu Y 2009 | 72 h | 79/43 | 65.1 (43–73) | 62 | SXT | 6 ml | 60 | XST2 | 8 ml | 14d | (1) | 1 |
Luo XD 2011 | 72 h | 35/25 | 61.8 | 30 | XST2 | 0.4 g | 30 | AADN | – | 14d | (1)(2) | 3 |
Liao MJ 2014 | 6-72 h | 43/17 | 62.5 (36–80) | 30 | HHHSS | 100 ml | 30 | XST2 | 400 mg | 14d | (1) | Unclear |
Shi JL 2010 | 72 h | 51/33 | 62 | 42 | YXDM | 20 ml | 42 | LI | 200 mg | 30d | (2) | Unclear |
Ni H 2010 | 24 h | 61/55 | 62.7 (54–74) | 59 | SXN | 20 ml | 57 | AADN | – | 14d | (1) | Unclear |
Li CP 2007 | 8-72 h | 106/54 | 63.8 (42–85) | 80 | SXN | 10-20 ml | 80 | AADN | – | 14d | (1) | Unclear |
Zhou ZP 2011 | 24 h | 48/33 | 62.2 | 42 | DZXX | 30 ml | 39 | AADN | – | 15d | (1) | Unclear |
Chen C 2015 | 72 h | 37/31 | 67.5 | 34 | SXT | 6 ml | 34 | XST2 | 400 mg | 14d | (1)(2) | 14 |
Chen JY 2012 | 72 h | 73/35 | 67 (40–76) | 54 | SXT | 6 ml | 54 | FFDS | 20 ml | 14d | (1)(2) | Unclear |
Luo QY 2007 | 72 h | 54/36 | 63.6 (37–81) | 45 | SXN | 6 ml | 45 | AADN | 20 ml | 14d | (1) | None |
Chen J 2007 | 72 h | 45/35 | 61 | 40 | YXDM | 20 ml | 40 | MLN | 20 ml | 15d | (1)(2)(3) | Unclear |
Zhang XL 2005 | 6d | 37/13 | 35–80 | 26 | MLN | 20 ml | 24 | FFDS | 20 m l | 21d | (2) | None |
Quality of the included studies
Pairwise meta-analysis
Pairwise meta-analysis of the markedly effective rate
AADN | 0.61(0.45,0.84) P = 0.96
i2
= 0% | 0.75(0.48,1.16) P = 0.97 l
2
= 0% | 0.72(0.42,1.23) P = 0.82 I
2
= 0% | 0.56(0.26,1.17) | – | 0.74(0.54,1.01) P = 0.91 I
2
= 0% | 0.67(0.40,1.14) P = 0.92 I
2
= 0% | 0.90(0.61,1.32) P = 0.71 I
2
= 0% | 0.93(0.46, 1.90) | 0.72(0.33, 1.59) | 0.81(0.54, 1.21) P = 0.79 I
2
= 0% | 0.61(0.30,1.26) | 0.57(0.44,0.73) P = 0.19 I
2
= 35.4% |
–
| |
3.89
(2.26, 6.26)
| DH | – | – | – | – | 1.53 (0.84,2.80) | – | – | – | – | 1.73 (0.89, 3.34) | – | – | 1.22 (0.69,2.16) | – |
0.8 (0.29, 1.8) | 0.22 (0.07,0.52) | DS | – | – | – | – | – | – | – | 0.79 (0.53,1.19) | 0.75 (0.41, 1.36) | – | 0.64 (0.28,1.47) | – | – |
2.14
(1.02, 3.99)
| 0.59 (0.23,1.23) | 3.3 (0.91,8.58) | DSCXQ | – | – | 1.70 (0.81,3.59) | – | – | – | – | – | – | – | – | – |
2.22 (0.95, 4.47) | 0.61 (0.22,1.35) | 3.38 (0.92,8.96) | 1.16 (0.37,2.82) | DZHS | – | – | – | – | 0.70 (0.32,1.48) | – | – | – | 0.75 (0.33,1.72) | – | |
5.36
(1.06,16.68)
| 1.47 (0.26,4.87) |
8.32
(1.12,30.55)
| 2.82 (0.44,9.73) | 2.82 (0.42,9.88) | DZXX | – | – | – | – | – | – | – | – | – | – |
0.94 (0.57, 1.46) | 0.25 (0.13,0.44) | 1.41 (0.51,3.11) | 0.49 (0.21,0.96) | 0.48 (0.19,1.01) |
0.29
(0.05,0.93)
| FFDS | – | 0.61(0.38, 0.98) P = 0.89 I
2
= 0% | 0.74(0.51,1.07)P = 0.86 I
2
= 0% | 0.76(0.33, 1.76) | 0.54(0.34,0.86)P = 0.70 I
2
= 0% | – | 0.75(0.53,1.06)P = 0.98 I
2
= 0% | 0.81(0.50,1.31)P = 0.65 I
2
= 0% | – |
3.34
(1.66, 6.14)
| 0.91 (0.37,1.91) |
5.14
(1.48,13.28)
| 1.75 (0.62,4) | 1.75 (0.56,4.22) | 1.02 (0.16,3.51) |
3.76
(1.61,7.65)
| HHHSS | – | – | – | 1.85 (0.79, 4.29) | – | – | – | – |
2.9
(1.36, 5.46)
| 0.79 (0.32,1.65) |
4.43
(1.29,11.37)
| 1.52 (0.53,3.47) | 1.51 (0.49,3.6) | 0.89 (0.14,3.03) |
3.18
(1.56,5.83)
| 0.97 (0.34,2.21) | SX | – | – | – | – | – | – | – |
3.27
(1.86, 5.35)
| 0.89 (0.42,1.66) |
4.96
(1.68,11.54)
| 1.71 (0.68,3.58) | 1.68 (0.67,3.51) | 1 (0.17,3.27) |
3.6
(2.03,5.97)
| 1.09 (0.44,2.23) | 1.25 (0.52,2.55) | SXT | – | 1.38(0.86, 2.22) P = 0.86 I
2
= 0% | 1.47 (0.79, 2.78) | – | – | – |
1.27 (0.53, 2.6) | 0.34 (0.13,0.76) | 1.78 (0.7,3.81) | 0.66 (0.21,1.62) | 0.66 (0.2,1.63) | 0.39 (0.06,1.38) | 1.39 (0.59,2.84) | 0.42 (0.14,1) | 0.49 (0.16,1.16) | 0.41 (0.16,0.87) | XST1 | 0.65 (0.37, 1.15) | – | – | – | – |
2.24
(1.23, 3.77)
| 0.61 (0.29,1.12) |
3.31
(1.25,7.23)
| 1.17 (0.46,2.51) | 1.16 (0.43,2.56) | 0.68 (0.12,2.28) |
2.47
(1.36,4.14)
| 0.74 (0.31,1.5) | 0.86 (0.35,1.77) | 0.71 (0.38,1.25) | 1.99 (0.85,3.94) | XST2 | – | – | – | – |
1.64 (0.78, 3.09) | 0.45 (0.18,0.96) | 2.54 (0.7,6.6) | 0.86 (0.29,2.01) | 0.86 (0.27,2.06) | 0.5 (0.08,1.73) | 1.85 (0.76,3.8) | 0.55 (0.19,1.25) | 0.64 (0.22,1.48) | 0.53 (0.22,1.07) | 1.52 (0.47,3.66) | 0.79 (0.31,1.68) | LI | – | – | – |
2.99
(1.53, 5.34)
| 0.81 (0.36,1.6) |
4.43
(1.57,10.1)
| 1.56 (0.59,3.4) | 1.52 (0.59,3.24) | 0.91 (0.15,3.1) |
3.24
(1.85,5.34)
| 1 (0.37,2.17) | 1.14 (0.46,2.36) | 0.96 (0.45,1.82) |
2.69
(1.01,5.84)
| 1.41 (0.65,2.69) | 2.05 (0.74,4.58) | YXDM | – | 1.32 (0.67,2.61) |
3.3
(2, 5.14)
| 0.9 (0.46,1.59) |
5.09
(1.64,12.18)
| 1.73 (0.71,3.61) | 1.73 (0.64,3.79) | 1.01 (0.18,3.3) |
3.69
(1.97,6.31)
| 1.1 (0.45,2.25) | 1.28 (0.53,2.61) | 1.08 (0.52,1.98) |
3.04
(1.12,6.65)
| 1.59 (0.75,2.97) | 2.27 (0.91,4.75) | 1.21 (0.54,2.33) | SXN | – |
1.33 (0.2, 4.65) | 0.36 (0.05,1.3) | 1.98 (0.24,7.46) | 0.69 (0.09,2.61) | 0.68 (0.09,2.47) | 0.41 (0.03,1.84) | 1.45 (0.23,4.95) | 0.44 (0.06,1.65) | 0.51 (0.07,1.86) | 0.43 (0.06,1.52) | 1.2 (0.15,4.48) | 0.63 (0.09,2.24) | 0.91 (0.11,3.45) | 0.45 (0.08,1.44) | 0.42 (0.06,1.51) | MLN |
Pairwise meta-analysis of the improvement of neurological impairment
AADN | 0.54(0.33, 0.75) I
2
= 13.4% P = 0.32 | – | 0.51(− 0.02, 1.03) I2 = 79.8% P = 0.007 | 1.01(0.04, 1.98) I
2
= 85.2% P = 0.009 | – | – | 0.64(0.44, 0.84) I
2
= 87.2% P = 0.000 | 0.77(0.43, 1.11) I
2
= 0% P = 0.60 |
0.79(0.44,1.14)
| – |
0.53(0.01, 1.04)
|
0.83
(0.51, 1.16) I
2
= 80.4% P = 0.02 |
1.03(0.56, 1.50)
|
0.41(0.15, 0.66)
| – |
− 0.71 (− 1.28,-0.13) | DH | – | – | – | – |
− 1.01
(− 1.40,-0.62)
| – | – | – | – |
− 0.61
(− 1.02,-0.20)
| – | – | – | |
− 0.83 (− 2.21,0.56) | −0.12 (− 1.58,1.3) | DS | – | – | – | – | – | – | – | – | – | – | 0.31 (− 0.20, 0.81) | – | – |
− 0.52 (− 1.15,0.1) | 0.19 (− 0.64,1.01) | 0.31 (− 1.18,1.8) | DSCXQ | – | – |
− 0.82
(− 1.27,-0.37)
| – | – | – | – | – | – | – | – | – |
−0.59 (− 1.26,0.07) | 0.12 (− 0.74,0.96) | 0.24 (− 1.23,1.69) | −0.07 (− 0.96,0.8) | DZHS | – | – | – | – |
0.84
(0.35, 1.33)
| – | – | – |
0.75
(0.24, 1.26)
| – | – |
−0.78 (− 2.19,0.63) | −0.07 (− 1.57,1.41) | 0.05 (− 1.88,1.97) | −0.26 (− 1.78,1.2) | −0.19 (− 1.68,1.2) | DZXX | – | – | – | 0.03 (− 0.49, 0.55) | – | – | – | – | – | – |
0.22 (− 0.3,0.73) |
0.92
(0.26,1.58)
| 1.05 (− 0.32,2.4) |
0.74
(0.01,1.47)
|
0.81
(0.05,1.58)
| 1.00 (− 0.43,2.43) | FFDS | – | 0.79 (0.45,1.13) I
2
= 0% P = 1 | 0.07 (−0.03, 0.45) |
1.15
(0.58, 1.71)
|
0.95
(0.49, 1.41)
| – | 1.31 (−0.05,2.66) I
2
= 95.7% P = 0 |
2.41
(1.85, 2.97)
| 0.44 (−0.12, 1.01) |
−0.78
(− 1.47,-0.09)
| − 0.07 (− 0.97,0.83) | 0.05 (− 1.49,1.58) | −0.26 (− 1.19,0.6) | −0.19 (− 1.16,0.7) | 0 (− 1.57,1.57) |
− 1
(− 1.86,-0.13)
| HHHSS | – | – | – | – | – | – | – | – |
− 0.67 (− 1.34,0) | 0.04 (− 0.8,0.87) | 0.16 (− 1.34,1.64) | −0.14 (− 1.03,0.7) | −0.08 (− 0.99,0.8) | 0.11 (− 1.41,1.64) |
−0.88
(− 1.55,-0.21)
| 0.11 (− 0.85,1.08) | SX | – | – | – | – | – | – | – |
− 0.81
(− 1.44,− 0.18)
| -0.1 (− 0.89,0.69) | 0.02 (− 1.44,1.47) | −0.29 (− 1.14,0.5) | −0.22 (− 0.99,0.5) | −0.03 (− 1.29,1.23) |
−1.03
(− 1.7,-0.36)
| −0.03 (− 0.97,0.91) | −0.14 (− 1,0.72) | SXT | – | − 0.20 (− 0.68,0.28) | −0.79 (− 1.19,-0.39) | – | – | – |
− 0.6 (− 1.61,0.39) | 0.11 (− 0.97,1.16) | 0.23 (−1.41,1.85) | −0.08 (− 1.22,1.0) | −0.01 (− 1.16,1.1) | 0.18 (− 1.48,1.83) | −0.82 (− 1.76,0.12) | 0.18 (−1.05,1.39) | 0.06 (− 1.06,1.18) | 0.21 (− 0.87,1.28) | XST1 | 0.24 (− 0.10,0.58) | – | – | – | – |
−0.56 (− 1.22,0.09) | 0.14 (− 0.59,0.88) | 0.27 (− 1.22,1.75) | −0.04 (− 0.92,0.8) | 0.03 (− 0.85,0.9) | 0.22 (−1.25,1.69) |
−0.78
(− 1.44,-0.12)
| 0.22 (− 0.74,1.17) | 0.1 (− 0.77,0.97) | 0.25 (− 0.5,1) | 0.04 (− 0.88,0.97) | XST2 | – | – | – | – |
−0.47 (− 1.13,0.19) | 0.24 (− 0.61,1.08) | 0.36 (−1.09,1.82) | 0.05 (− 0.84,0.9) | 0.12 (− 0.74,0.9) | 0.31 (− 1.16,1.79) | −0.69 (− 1.43,0.07) | 0.31 (− 0.65,1.27) | 0.2 (− 0.71,1.1) | 0.34 (− 0.42,1.1) | 0.13 (−1.01,1.28) | 0.09 (− 0.78,0.96) | LI |
0.96
(0.51, 1.42)
| – | – |
−1.14
(− 1.74,-0.54)
| −0.43 (− 1.19,0.34) | −0.31 (− 1.57,0.94) | −0.61 (− 1.43,0.2) | −0.55 (− 1.3,0.22) | −0.36 (− 1.82,1.12) |
−1.35
(− 1.89,-0.81)
| −0.36 (− 1.27,0.56) | −0.47 (− 1.28,0.33) | −0.33 (− 1.08,0.42) | −0.53 (− 1.59,0.52) | −0.57 (− 1.36,0.21) | −0.67 (− 1.42,0.08) | YXDM | – |
0.51
(0.06,0.95)
|
−1.25
(− 2.14,-0.37)
| − 0.54 (− 1.56,0.47) | −0.41 (− 2.01,1.18) | −0.72 (− 1.79,0.3) | −0.65 (− 1.73,0.4) | −0.46 (− 2.09,1.17) |
− 1.46
(− 2.36,-0.58)
| −0.47 (− 1.6,0.65) | −0.58 (− 1.63,0.48) | −0.43 (− 1.48,0.59) | −0.64 (− 1.9,0.62) | −0.68 (− 1.73,0.36) | −0.77 (− 1.86,0.29) | −0.11 (− 1.1,0.88) | SXN | – |
− 0.44 (− 1.45,0.57) | 0.27 (− 0.84,1.37) | 0.39 (− 1.16,1.94) | 0.09 (− 1.06,1.2) | 0.16 (− 0.98,1.2) | 0.35 (− 1.32,2.02) | −0.65 (− 1.58,0.27) | 0.34 (− 0.89,1.57) | 0.23 (− 0.9,1.36) | 0.37 (− 0.73,1.48) | 0.17 (− 1.14,1.48) | 0.13 (− 0.99,1.24) | 0.03 (− 1.1,1.17) | 0.7 (− 0.22,1.62) | 0.81 (− 0.45,2.08) | MLN |